GeneIQ
Medical and Diagnostic LaboratoriesTexas, United States11-50 Employees
GeneIQ is a molecular diagnostics laboratory based in The Colony, Texas, specializing in pharmacogenomic testing. Its core offering is a comprehensive panel of 35 genes designed to forecast how individuals metabolize medications, supporting treatment decisions. The gene panel spans a wide range of medical areas, including addiction, cardiology, diabetes, gastroenterology, neurology, oncology, orthopedics, pain management, psychiatry, and rheumatology. The company emphasizes a strong collaboration between its laboratory and scientific teams to deliver results efficiently and provide patient support. Operating within the medical and diagnostic laboratories sector, GeneIQ aims to translate genomic data into clinically actionable insights for healthcare providers and patients. By informing medication choices and dosing based on DNA, the organization seeks to reduce variability in drug response and improve therapeutic outcomes. The company highlights robust processes and modern instrumentation to expedite results and maintain patient assistance. In early 2021, GeneIQ announced the launch of a four-in-one PCR test capable of detecting influenza A and B, RSV, and SARS-CoV-2.